616 S15/NS1 RNA-binding domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 9 | 6.3 | 1.43× | q = 0.23 | |
| Mixed metal/non-metal compounds | 2 | 0.3 | 7.43× | not tested | |
| Organic nitrogen compounds | 2 | 0.4 | 4.89× | not tested | |
| Organic acids and derivatives | 2 | 2.0 | 1.01× | not tested | |
| Organic oxygen compounds | 1 | 2.6 | 0.39× | not tested | |
| Homogeneous non-metal compounds | 1 | 2.8 | 0.36× | not tested | |
| Nucleosides, nucleotides, and analogues | 1 | 3.5 | 0.28× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 15 |
| DB00139 | SIN | Succinic acid | 2 |
| DB00145 | GLY | Glycine | 2 |
| DB00160 | ALA | Alanine | 1 |
| DB03309 | NHE | N-cyclohexyltaurine | 1 |
| DB03566 | SPD | Spermidine | 1 |
| DB11638 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MGmetal | MAGNESIUM ION | 217 |
| OHX | osmium (III) hexammine | 77 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 34 |
| Kmetal | POTASSIUM ION | 10 |
| PAR | PAROMOMYCIN | 8 |
| NAmetal | SODIUM ION | 5 |
| 8UZ | TC007 | 3 |
| GLY | GLYCINE | 3 |
| BR | BROMIDE ION | 2 |
| SIN | SUCCINIC ACID | 2 |
| SPD | SPERMIDINE | 2 |
| UNX | UNKNOWN ATOM OR ION | 2 |
| D10 | DECANE | 1 |
| HEX | HEXANE | 1 |
| HY0 | HYGROMYCIN B VARIANT | 1 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 1 |
| NHE | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | 1 |
| PGW | (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl(9Z)-octadec-9-enoate | 1 |
| PLM | PALMITIC ACID | 1 |
| PX2 | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHATE | 1 |